Highlights
- Total Q1 sales reached 365, with 177 new sales and 188 resales
- New sales up 34% YoY, resales up 19% YoY
- Development pipeline remains strong with 650–700 homes in NZ and 100–150 in Australia planned
Summerset Group Limited (NZX: SUM) reported robust sales performance for Q1 2026, totaling 365 occupation rights, including 177 new sales and 188 resales. Compared to Q1 2025, new sales rose 34% while resales grew 19%, demonstrating continued demand across Summerset’s villages despite the typical seasonal slowdown in January and early February. CEO Scott Scoullar highlighted the company’s strong sales pipeline heading into Q2. During the quarter, Summerset opened village centre facilities in Cambridge and Waikanae, with new developments in Mt Denby (Whangarei) and Cranbourne North (Victoria, Australia) scheduled for Q2. While monitoring rising fuel prices and geopolitical uncertainties, the company reported no immediate impact on sales or demand and remains focused on cost management and operational resilience, supported by a strong balance sheet and banking facilities.
Sales Momentum and Development Pipeline
The company’s Q1 performance reflects sustained interest in Summerset’s retirement villages, with broad-based participation in both new and resale transactions. In addition to opening village centres at Cambridge and Waikanae, Summerset has projects lined up in Mt Denby and Cranbourne North for Q2, reinforcing its growth strategy. With 650–700 homes planned in New Zealand and 100–150 in Australia for 2026, the company’s development pipeline remains robust, supporting long-term demand and expansion goals.
Managing Market Risks and Costs
Summerset is closely monitoring fuel price increases and geopolitical developments, particularly the Middle East conflict, to assess potential impacts on costs and demand. CEO Scott Scoullar reported that, so far, sales contracts have risen by approximately 13% over the year-to-date average, with cancellations stable. Construction costs remain manageable due to a strong procurement programme. The company is well-prepared to handle price volatility, leveraging a solid balance sheet, ample banking headroom, and operational flexibility. Management remains focused on cost control and adaptability, ensuring Summerset can navigate any market uncertainties while continuing its growth trajectory.
FAQs
How did Summerset Group perform in Q1 2026?
Summerset recorded 365 sales, with 177 new sales and 188 resales, marking a 34% increase in new sales and 19% in resales compared to Q1 2025.
Are fuel prices affecting Summerset’s sales or costs?
So far, rising fuel prices have not impacted sales or demand, and construction costs remain stable thanks to a strong procurement strategy.
What is Summerset’s development plan for 2026?
The company plans to build 650–700 homes in New Zealand and 100–150 in Australia, with several village openings scheduled in Q2 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
This report (“Report”) has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this Report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine).
The information in this Report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its reports (including this Report), newsletters and websites. All information represents our views at the date of publication and may change without notice.
Kalkine does not issue, sell or deal in any financial products. The information in this Report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain general recommendations to invest in securities and other financial products. Kalkine is not responsible for, and does not guarantee, the performance of, or returns on, any investments mentioned in this Report.
This Report may contain information on past performance of particular investments. Past performance is not a reliable indicator of future performance. Returns stated do not take into account transaction costs and taxes.
Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.
Copyright 2026 Krish Capital Pty. Ltd. (ABN 61629651510). All Rights Reserved. No part of this Report, or its content, may be reproduced in any form without our prior consent.